Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 425 publications
French recommendations from the AFU Cancer Committee for prostate cancer 2025 Summary of changes.
Journal: The French journal of urology
Published: October 06, 2025
The addition of darolutamide to androgen deprivation therapy in metastatic hormone-sensitive prostate cancer.
Journal: Clinical advances in hematology & oncology : H&O
Published: July 29, 2025
Unmasking recurrent melena as the initial presentation of metastatic prostate cancer: a case report.
Unmasking recurrent melena as the initial presentation of metastatic prostate cancer: a case report.
Journal: Frontiers in oncology
Published: July 28, 2025
Matching-adjusted indirect comparison of enzalutamide versus darolutamide doublet in mHSPC.
Journal: Future oncology (London, England)
Published: July 14, 2025
PEGylated liposomes co-encapsulating darolutamide and hesperetin for enhanced prostate cancer therapy: 2D, 3D PC3 models and in-vivo evaluation.
Journal: Biomaterials advances
Published: July 11, 2025
Rhabdomyolysis induced by darolutamide and rosuvastatin.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 07, 2025
Comparative neurological safety of novel hormonal therapies in advanced prostate cancer: a Bayesian network meta-analysis of randomized trials.
Journal: International journal of clinical oncology
Published: June 30, 2025
Real-Life Use Patterns of Androgen Receptor Pathway Inhibitors (ARPIs): A Nationwide Register-Based Study in Finland During 2012-2023.
Journal: Cancers
Published: June 27, 2025
Precision targeting of androgen receptor-ferroptosis crosstalk in prostate cancer: From mechanisms to therapeutic strategies.
Journal: Pharmacological research
Published: June 20, 2025
A Case of Triplet Therapy Showing Remarkable Efficacy for Multiorgan Metastatic Recurrence After Radical Prostatectomy in Prostate Cancer.
Journal: IJU case reports
Published: June 16, 2025
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate Cancer.
Journal: European urology oncology
Published: June 13, 2025
Last Updated: 10/31/2025